Výsledky vyhledávání - "Ljubomir, Petrov"

Effect of long period treatment with erythropoiesis stimulating agents on clinically and laboratory parameters in hemodialysis autosomal dominant polycystic kidney disease patients

Autor: Remus Aurel Orasan, George Ciulei, Ljubomir Petrov, Laura Urian, Ioan Mihai Patiu, Olga Hilda Orasan, Angela Cozma

Publikováno v: Romanian Journal of Laboratory Medicine, Vol 25, Iss 4, Pp 375-382 (2017)

Introduction. The study of dialysis patients not needing erythropoiesis-stimulating agents (ESA) for long periods of time has gained interest lately. The aim of this study was to compare laboratory and clinical parameters in hemodialysis patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79e7315a1ef3ae281e46fa057fc1b0de
https://doi.org/10.1515/rrlm-2017-0032

Zobrazit plný text záznamu

Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania

Autor: Cosmin Lisencu, Cristian Berce, Ljubomir Petrov, Petru Ilies, Alina Tanase, Delia Dima, Florin Zaharie, Ioana Frinc, Alexandru Irimie, Ioana Berindan-Neagoe, Ciprian Tomuleasa, Anca Bojan

Publikováno v: Romanian Journal of Internal Medicine, Vol 55, Iss 2, Pp 103-116 (2017)

In the past decade, there has been significant progress in clinical hematology with the discovery of targeted molecules and thus the achievement of both hematologic and molecular responses. Nevertheless, chemotherapy remains the treatment of choice f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4477711fffe3ccc20aa767d4e43a6553
https://doaj.org/article/1f836ec70e6b47f69f5681bfc1d2b4cb

Zobrazit plný text záznamu

CX3CR1 expression and megakaryocytic series assessment on bone marrow biopsies in acquired aplastic anemia. Correlations with hematological parameters

Autor: Bogdan Fetica, Laura Urian, Ljubomir Petrov, Cosmina Bondor, Cosmina Ioana Gavrilut, Annamaria Fulop

Publikováno v: Romanian Journal of Laboratory Medicine, Vol 23, Iss 4, Pp 483-494 (2015)

The study objective was to examine the clinical and hematological significance of receptor CX3CR1 and megakaryocytes in patients with aplastic anemia. Method. 40 patients diagnosed with aplastic anemia and 10 case-control were included in the study.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7cfd5b69635a6691b98ce2115b884a
https://doi.org/10.1515/rrlm-2015-0040

Zobrazit plný text záznamu

Non-Hodgkin lymphoma in Romania: a single-centre experience

Autor: Ljubomir Petrov, Hans K. Müller-Hermelink, Annamaria Fulop, Florian Nicula, Daniela Coza, Patriciu Achimas-Cadariu, Alexandru Irimie, Dennis D. Weisenburger, Jacques Diebold, Bogdan Pop, Mihaiela L. Blaga, Bharat N. Nathwani, Kenneth A. MacLennan, Anamarija M. Perry, Bogdan Fetica, Delia Dima

Publikováno v: Hematological Oncology. 35:198-205

Epidemiologic studies of non-Hodgkin lymphoma (NHL) in Eastern Europe are scarce in the literature. We report the experience of the "Ion Chiricuta" Institute of Oncology in Cluj-Napoca (IOCN), Romania, in the diagnosis and outcome of patients with NH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::726186ee8f5275de4a738ee4888a2dbf
https://doi.org/10.1002/hon.2266

Zobrazit plný text záznamu

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase:ENEST1st sub-analysis

Autor: Maria Liz Paciello Coronel, Beatrice Vincenzi, Ljubomir Petrov, Fausto Castagnetti, Delphine Rea, Andrzej Hellmann, Francis J. Giles, Andreas Hochhaus, Valentin Garcia-Gutierrez, Maria Asuncion Echeveste Gutierrez, Franҫois-Xavier Mahon, Luca Dezzani, Philipp le Coutre, Gianantonio Rosti, Norbert Gattermann, Nicholas C.P. Cross, Jeroen Janssen

Publikováno v: Hochhaus, A, Mahon, F-X, le Coutre, P, Petrov, L, Janssen, J J W M, Cross, N C P, Rea, D, Castagnetti, F, Hellmann, A, Rosti, G, Gattermann, N, Coronel, M L P, Gutierrez, M A E, Garcia-Gutierrez, V, Vincenzi, B, Dezzani, L & Giles, F J 2017, ' Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase : ENEST1st sub-analysis ', Journal of Cancer Research and Clinical Oncology, vol. 143, no. 7, pp. 1225-1233 . https://doi.org/10.1007/s00432-017-2359-9
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 143(7), 1225-1233. Springer Verlag
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

PURPOSE: The ENEST1st sub-analysis presents data based on Philadelphia chromosome (Ph) status, i.e., Ph+ and Ph-/BCR-ABL1 + chronic myeloid leukemia.METHODS: Patients received nilotinib 300 mg twice daily, up to 24 months.RESULTS: At screening, 983 p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32a0b316372c1eb5fd4577816af80c2
https://research.vumc.nl/en/publications/0d7cc258-28f1-462e-bdd2-52e52f3fc3b9

Zobrazit plný text záznamu

Castleman Disease. A Report of Six Cases

Autor: Andrei Cucuianu, Bogdan Fetica, Aurel Coman, Cosmin Lisencu, Ljubomir Petrov, Bogdan Pop, A. Rancea

Publikováno v: Clujul Medical

Backgroud and aims: Castleman’s disease is a rare disorder situated at the boundary between reactive and neoplastic conditions. The pathogenesis is a subject of debate and the limited number of cases renders the study of the disease difficult. In o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba38c76be62a7e5f1ca8f527d03a913
http://europepmc.org/articles/PMC4508595

Zobrazit plný text záznamu

Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation

Autor: Andrei Cucuianu, Ljubomir Petrov, Cristian S. Vesa, Delia Dima, Ioana Frinc, Mariana Paţiu, Adrian P. Trifa

Publikováno v: Romanian Journal of Laboratory Medicine, Vol 21, Iss 1, Pp 29-37 (2013)

De la introducerea inhibitorului de tirozinkinază (ITK) imatinib mesylate (IM) în terapia leucemiei mieloide cronice (LMC), s-a obsen’at o îmbunătăţire dramatică a răspunsului hematologic, citogenetic şi molecular. Din păcate, la o parte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798f65d32bacadec447e16e68b3a7a4e
https://doaj.org/article/3480bed270ac4460afc1512cf685d20c

Zobrazit plný text záznamu

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the European ENEST1st study

Publikováno v: Leukemia
Leukemia, London : Nature Publishing Group, 2016, vol. 30, no 1, p. 57-64
Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M & Giles, F J 2016, ' Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase : results from the European ENEST1st study ', Leukemia, vol. 30, no. 1, pp. 57-64 . https://doi.org/10.1038/leu.2015.270
Leukemia : normal and malignant hemopoiesis 30(1), 57-64 (2016). doi:10.1038/leu.2015.270
Leukemia, 30(1), 57-64. Nature Publishing Group
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

The Evaluating Nilotinib Efficacy and Safety in Clinical Trials as First-Line Treatment (ENEST1st) study included 1089 patients with newly diagnosed chronic myeloid leukemia in chronic phase. The rate of deep molecular response (MR4 (BCR-ABL1less tha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437d5dc51205d583c4afd5ab789a674d
http://hdl.handle.net/2318/1586333

Zobrazit plný text záznamu

The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms

Autor: Mariela S. Militaru, Ljubomir Petrov, Delia Dima, Laura Urian, Radu A. Popp, Andrei Cucuianu, Ioan Victor Pop, Adrian P. Trifa

Publikováno v: Annals of Hematology. 89:979-983

Polycythemia vera, essential thrombocythemia, and primary myelofibrosis are myeloproliferative neoplasms, characterized in a majority of cases by a unique somatic point mutation, JAK2 V617F. Recently, it was shown that JAK2 V617F occurs more frequent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4181b01015721ad9bbc39853af0f26
https://doi.org/10.1007/s00277-010-0960-y

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání